Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Gilead Sciences, targeting a price of $105. Maintaining their stance, an analyst from Morgan Stanley ...
Exxon Mobil Corp. plunged the most in six months after higher-than-expected maintenance costs diminished oil-refining results ...
Whether you're a first-time investor or a seasoned property owner, a 1031 exchange can impact your tax strategy significantly ...
Q1 2024 Earnings Call Transcript April 25, 2024 Barclays PLC misses on earnings expectations. Reported EPS is $0.21 EPS, ...
Investors are digesting the Fed's preferred inflation measure after the release of the Personal Consumption Expenditures (PCE ...